Results for “ ”

Entry Author Date Location
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D 09/17/20 Boston
BIO Chief: “Reckless” Executive Order on Drug Prices Threatens Innovation 09/17/20 Boston
Finch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline 09/17/20 Boston
Arrowhead Pharma Shares Soar on Early Liver Data for RNAi Drug 09/16/20 Wisconsin
Moderna CMO Talks COVID-19 Vaccine at Xcelerate Next Week 09/16/20 Boston
Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy 09/15/20 Europe
Xconomy Awards On-Demand ‘Meet the Finalists’ Webcast Series Continues This Week 09/14/20 Boston
Join Xconomy Next Week at the Virtual Xcelerate Keynote Series at Biotech Week Boston 09/14/20 Boston
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans 09/10/20 Boston
Generate Bio Aims to Reveal Nature’s Protein Secrets, Create New Drugs 09/10/20 Boston
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue 09/09/20 National
Grifols Moves Deeper Into Proteome R&D With $146M Deal for Alkahest 09/08/20 San Francisco
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures 09/05/20 Boston
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally 09/03/20 Boston
Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs 09/02/20 Seattle
Gilead Sciences Places $120M Bet on a Jounce Therapeutics Cancer Drug 09/01/20 San Francisco
Early Bird Sale for Xcelerate at Biotech Week Boston Ends This Friday 08/31/20 Boston
Akcea Therapeutics Is Returning to Parent Ionis Pharma in $500M Buyout 08/31/20 Boston
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Freenome Tacks on $270M to Advance Blood Tests to Find Cancer Early 08/26/20 San Francisco
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases 08/26/20 Boston
FDA Adds Plasma as 2nd COVID-19 Treatment Under Emergency Guidelines 08/24/20 National
Yumanity to Merge With Proteostasis to Advance Neuro Drug Pipeline 08/24/20 Boston
Astellas Reports Third Patient Death in Audentes Gene Therapy Study 08/21/20 San Francisco
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
Alzheon Lands $47M to Take Another Shot at a Pivotal Alzheimer’s Test 08/20/20 Boston
J&J Boosts Autoimmune Disease Drug Pipeline With $6.5B Momenta Buyout 08/19/20 New York
Page 1 of 636 next page »